Open AccessGadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma
Author(s) -
Yi-Chen Chou,
I-Ha Lao,
Pei-Ling Hsieh,
Ying-Ying Su,
Chee-Wai Mak,
Ding-Ping Sun,
MingJen Sheu,
HsingTao Kuo,
TzuJu Chen,
Chung Han Ho,
YuTing Kuo
Publication year - 2019
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v25.i21.2636
Subject(s) - gadoxetic acid , medicine , magnetic resonance imaging , hepatocellular carcinoma , hyperintensity , radiology , stage (stratigraphy) , odds ratio , effective diffusion coefficient , confidence interval , pathology , nuclear medicine , paleontology , biology , gadolinium dtpa
Although important for determining long-term outcome, pathologic stage of hepatocellular carcinoma (HCC) is difficult to predict before surgery. Current state-of-the-art magnetic resonance imaging (MRI) using gadoxetic acid provides many imaging features that could potentially be used to classify single HCC as pT1 or pT2.